U.S. flag

An official website of the United States government

NM_207581.4(DUOXA2):c.95dup (p.Leu32fs) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 8, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001383582.4

Allele description [Variation Report for NM_207581.4(DUOXA2):c.95dup (p.Leu32fs)]

NM_207581.4(DUOXA2):c.95dup (p.Leu32fs)

Gene:
DUOXA2:dual oxidase maturation factor 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_207581.4(DUOXA2):c.95dup (p.Leu32fs)
HGVS:
  • NC_000015.10:g.45114700dup
  • NG_009447.1:g.4466dup
  • NG_016992.1:g.5376dup
  • NM_207581.4:c.95dupMANE SELECT
  • NP_997464.2:p.Leu32fs
  • NC_000015.9:g.45406893_45406894insT
  • NC_000015.9:g.45406898dup
  • NM_207581.3:c.95dup
Protein change:
L32fs
Links:
dbSNP: rs974496530
NCBI 1000 Genomes Browser:
rs974496530
Molecular consequence:
  • NM_207581.4:c.95dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001582772Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Feb 8, 2018)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism.

Zamproni I, Grasberger H, Cortinovis F, Vigone MC, Chiumello G, Mora S, Onigata K, Fugazzola L, Refetoff S, Persani L, Weber G.

J Clin Endocrinol Metab. 2008 Feb;93(2):605-10. Epub 2007 Nov 27.

PubMed [citation]
PMID:
18042646
PMCID:
PMC2243227

A novel dual oxidase maturation factor 2 gene mutation for congenital hypothyroidism.

Yi RH, Zhu WB, Yang LY, Lan L, Chen Y, Zhou JF, Wang J, Su YQ.

Int J Mol Med. 2013 Feb;31(2):467-70. doi: 10.3892/ijmm.2012.1223. Epub 2012 Dec 24.

PubMed [citation]
PMID:
23292166
See all PubMed Citations (4)

Details of each submission

From Invitae, SCV001582772.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Leu32Phefs*78) in the DUOXA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DUOXA2 are known to be pathogenic (PMID: 18042646, 23292166, 25675383). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with DUOXA2-related disease. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024